JP2020511114A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511114A5
JP2020511114A5 JP2019530815A JP2019530815A JP2020511114A5 JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5 JP 2019530815 A JP2019530815 A JP 2019530815A JP 2019530815 A JP2019530815 A JP 2019530815A JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5
Authority
JP
Japan
Prior art keywords
adenovirus
acid sequence
amino acid
seq
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019530815A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511114A (ja
Filing date
Publication date
Priority claimed from GBGB1620968.6A external-priority patent/GB201620968D0/en
Application filed filed Critical
Publication of JP2020511114A publication Critical patent/JP2020511114A/ja
Publication of JP2020511114A5 publication Critical patent/JP2020511114A5/ja
Pending legal-status Critical Current

Links

JP2019530815A 2016-12-09 2017-12-07 アデノウイルスポリヌクレオチド及びポリペプチド Pending JP2020511114A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1620968.6 2016-12-09
GBGB1620968.6A GB201620968D0 (en) 2016-12-09 2016-12-09 Adenovirus polynucleotides and polypeptides
PCT/IB2017/057738 WO2018104911A1 (en) 2016-12-09 2017-12-07 Adenovirus polynucleotides and polypeptides

Publications (2)

Publication Number Publication Date
JP2020511114A JP2020511114A (ja) 2020-04-16
JP2020511114A5 true JP2020511114A5 (cg-RX-API-DMAC7.html) 2021-01-21

Family

ID=58222021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019530815A Pending JP2020511114A (ja) 2016-12-09 2017-12-07 アデノウイルスポリヌクレオチド及びポリペプチド

Country Status (15)

Country Link
US (2) US11414679B2 (cg-RX-API-DMAC7.html)
EP (1) EP3551224A1 (cg-RX-API-DMAC7.html)
JP (1) JP2020511114A (cg-RX-API-DMAC7.html)
KR (1) KR20190092471A (cg-RX-API-DMAC7.html)
CN (1) CN110300597A (cg-RX-API-DMAC7.html)
AR (1) AR110502A1 (cg-RX-API-DMAC7.html)
AU (1) AU2017371944B2 (cg-RX-API-DMAC7.html)
BE (1) BE1025029B1 (cg-RX-API-DMAC7.html)
BR (1) BR112019010906A2 (cg-RX-API-DMAC7.html)
CA (1) CA3045973A1 (cg-RX-API-DMAC7.html)
EA (1) EA201991116A1 (cg-RX-API-DMAC7.html)
GB (1) GB201620968D0 (cg-RX-API-DMAC7.html)
IL (1) IL266942A (cg-RX-API-DMAC7.html)
MX (1) MX2019006725A (cg-RX-API-DMAC7.html)
WO (1) WO2018104911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201507393TA (en) 2013-03-14 2015-10-29 Salk Inst For Biological Studi Oncolytic adenovirus compositions
ES2899913T3 (es) 2014-09-24 2022-03-15 Salk Inst For Biological Studi Virus tumorales oncolíticos y métodos de uso
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
EP3390645B1 (en) 2016-02-23 2022-09-14 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
GB201620968D0 (en) * 2016-12-09 2017-01-25 Glaxosmithkline Biologicals Sa Adenovirus polynucleotides and polypeptides
AU2017375633C1 (en) 2016-12-12 2023-04-27 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
KR102945203B1 (ko) 2017-05-08 2026-03-31 시애틀 프로젝트 코포레이션 알파바이러스 신생항원 벡터
CN111108203A (zh) * 2017-07-17 2020-05-05 葛兰素史密丝克莱恩生物有限公司 狂犬病病毒抗原构建体
SG11202003058UA (en) * 2017-10-16 2020-04-29 Glaxosmithkline Biologicals Sa Replication competent adenoviral vectors
BR112020019942A2 (pt) 2018-04-09 2021-01-26 Salk Institute For Biological Studies composições de adenovírus oncolítico com propriedades de replicação aprimoradas
MX2020013553A (es) 2018-06-12 2021-02-26 Glaxosmithkline Biologicals Sa Polinucleotidos y polipeptidos de adenovirus.
BR112021000965A2 (pt) 2018-08-07 2021-04-27 Glaxosmithkline Biologicals S.A. processos e vacinas
KR20210090650A (ko) 2018-11-07 2021-07-20 그릿스톤 바이오, 인코포레이티드 알파바이러스 신생항원 벡터 및 인터페론 억제제
EP3897846A1 (en) 2018-12-21 2021-10-27 GlaxoSmithKline Biologicals SA Methods of inducing an immune response
SG11202113187WA (en) 2019-05-30 2021-12-30 Gritstone Bio Inc Modified adenoviruses
WO2021156489A1 (en) * 2020-02-05 2021-08-12 Imophoron Limited Engineered polypeptides derived from variable domain of adenovirus penton base
EP4133090A1 (en) * 2020-04-07 2023-02-15 Lung Biotechnology PBC Adenoviral expression vector and methods and cell lines for production
IL300026A (en) 2020-08-06 2023-03-01 Gritstone Bio Inc Multiepitope vaccine cassettes
GB202016139D0 (en) * 2020-10-12 2020-11-25 Ospedale San Raffaele Polynucleotide
JP2025523458A (ja) * 2022-06-22 2025-07-23 アスクバイオ インコーポレイテッド アデノウイルスに基づく核酸およびその方法
CN121816424A (zh) * 2023-08-11 2026-04-07 拜奥卡德联合股份公司 用于生产基于腺相关病毒(AAV)的载体(变体)的腺病毒E2a基因的修饰的序列

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5240846A (en) 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
JP3723231B2 (ja) 1991-12-23 2005-12-07 ディミナコ アクチェンゲゼルシャフト アジュバント
DE69313134T2 (de) 1992-06-25 1998-02-26 Smithkline Beecham Biolog Adjuvantien enthaltende impfstoffzusammensetzung
KR100310510B1 (ko) 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
PT729473E (pt) 1993-11-17 2001-02-28 Deutsche Om Arzneimittel Gmbh Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
GB9620795D0 (en) 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US6083716A (en) 1996-09-06 2000-07-04 The Trustees Of The University Of Pennsylvania Chimpanzee adenovirus vectors
WO1998016247A1 (en) 1996-10-11 1998-04-23 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US6764840B2 (en) 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
GB9711990D0 (en) 1997-06-11 1997-08-06 Smithkline Beecham Biolog Vaccine
AU734180B2 (en) 1997-08-29 2001-06-07 Antigenics Llc Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
EP1279401B1 (en) 1997-09-05 2008-01-09 GlaxoSmithKline Biologicals S.A. Oil in water emulsions containing saponins
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
WO2000011140A1 (en) 1998-08-20 2000-03-02 The Wistar Institute Of Anatomy And Biology Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
ES2284287T3 (es) 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
US7291498B2 (en) 2003-06-20 2007-11-06 The Trustees Of The University Of Pennsylvania Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
JP4814800B2 (ja) * 2004-01-23 2011-11-16 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー チンパンジーアデノウイルスワクチン担体
CA2610919C (en) 2005-06-17 2013-09-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hepatitis c virus nucleic acid vaccine
SI1957528T1 (sl) 2005-11-30 2013-02-28 University Of Copenhagen Nukleotidno cepivo
EP2181121A4 (en) 2007-03-21 2012-07-11 Id Biomedical Corp Quebec CHIMÄRE ANTIGENE
CN102131920B (zh) * 2007-11-28 2013-11-06 宾夕法尼亚大学托管会 猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用
SI2865387T1 (sl) 2008-11-21 2019-10-30 Kobenhavns Univ University Of Copenhagen Primiranje imunskega odziva
HUE039908T2 (hu) 2009-02-02 2019-02-28 Glaxosmithkline Biologicals Sa Majom adenovírusból származó nukleinsav- és aminosav-szekvenciák, azt tartalmazó vektorok és alkalmazásuk
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
JP6091435B2 (ja) 2011-02-22 2017-03-08 カリフォルニア インスティチュート オブ テクノロジー アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
WO2016198621A1 (en) 2015-06-12 2016-12-15 Glaxosmithkline Biologicals Sa Adenovirus polynucleotides and polypeptides
GB201620968D0 (en) * 2016-12-09 2017-01-25 Glaxosmithkline Biologicals Sa Adenovirus polynucleotides and polypeptides

Similar Documents

Publication Publication Date Title
JP2018524977A5 (cg-RX-API-DMAC7.html)
JP7274222B2 (ja) 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用
JP2020511940A5 (cg-RX-API-DMAC7.html)
AU737780B2 (en) Methods and reagents for vaccination which generate a CD8 T cell immune response
JP6873054B2 (ja) アデノウイルスポリヌクレオチド及びポリペプチド
JP7630466B2 (ja) 抗原がインバリアント鎖(cd74)の小断片と連結された融合ペプチド
JP7274223B2 (ja) マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン
JP2018523980A5 (cg-RX-API-DMAC7.html)
US20210269486A1 (en) Chimpanzee adenovirus constructs with lyssavirus antigens
JP2012516679A5 (cg-RX-API-DMAC7.html)
JP2026082958A (ja) ゴリラ・アデノウイルスの核酸配列およびアミノ酸配列、それを含むベクター、およびそれらの使用
JP2021526831A (ja) アデノウイルスポリヌクレオチド及びポリペプチド
CN118308379A (zh) 爱泼斯坦-巴尔病毒抗原构建体
HK40031047A (en) Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
HK40031047B (en) Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
AU775973B2 (en) Methods and reagents for vaccination which generate a CD8 T cell immune response
AU2004203141B2 (en) Methods and reagents for vaccination which generate CD8 T cell immune response
NZ759892B2 (en) Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof